Phospho-CD28 (Y218) Antibody

What is the significance of CD28-Y218 phosphorylation in T cell signaling?

CD28-Y218 is a tyrosine residue located in the C-terminus of CD28, a critical co-stimulatory receptor in T cells. Unlike the well-characterized YMNM and PYAP motifs, Y218 represents an additional phosphorylation site that becomes modified upon receptor activation. This phosphorylation event has been demonstrated to play a crucial role in regulating IL-2 and TNFα secretion in T cells. Research has shown that CD28-Y218 phosphorylation reaches maximum levels approximately 10 minutes after antigen stimulation, suggesting its involvement in early signaling events that shape downstream T cell responses .

How does CD28-Y218 phosphorylation differ from other phosphorylation sites on CD28?

CD28 contains several well-characterized tyrosine-containing motifs, including YMNM (Y191) and PYAP (Y209), which are known to be phosphorylated upon receptor activation. These sites recruit specific signaling molecules: Y191 primarily recruits phosphatidylinositol 3-kinase (PI3K) through its SH2 domains, while the PYAP motif interacts with adaptors like GRB2. Y218 phosphorylation represents a distinct regulatory mechanism that appears to be less abundant and more weakly inhibited by CTLA4-Ig treatment compared to Y191 and Y209 . Functionally, while Y191 and Y209 have established roles in T cell proliferation and survival, Y218 appears to have a more specialized role in regulating cytokine production, particularly IL-2 secretion .

Which kinases are responsible for CD28-Y218 phosphorylation?

Evidence indicates that IL-2-inducible T-cell kinase (ITK) plays a crucial role in CD28-Y218 phosphorylation. Studies using ITK-deficient Jurkat cells or ITK inhibitors have demonstrated reduced phosphorylation at this site. Additional kinases that may contribute to this phosphorylation event include protein-tyrosine kinase TEC and bone marrow tyrosine kinase (BMX), as suggested by in silico studies . Furthermore, research has shown that increasing ITK binding to CD28 (through the PYRP mutant) leads to approximately 2-fold higher IL-2 production, reinforcing ITK's importance in this signaling pathway .

What are the most reliable methods to detect CD28-Y218 phosphorylation?

Western blotting using phospho-specific antibodies remains the gold standard for detecting CD28-Y218 phosphorylation. Several commercial antibodies are available for this purpose, typically raised in rabbits against synthetic phosphopeptides corresponding to the region surrounding Y218 . For optimal results, researchers should:

• Stimulate cells appropriately (e.g., using target cells or anti-CD28 antibodies)

• Lyse cells at optimal time points (phosphorylation peaks around 10 minutes post-stimulation)

• Include appropriate controls (unstimulated cells and Y218F mutants)

• Use fresh lysates and include phosphatase inhibitors

Alternative approaches include flow cytometry with anti-phospho-CD28-Y218 antibodies for single-cell analysis, and ELISA for high-throughput screening of phosphorylation levels .

How should experiments be designed to study the kinetics of CD28-Y218 phosphorylation?

To effectively study the kinetics of CD28-Y218 phosphorylation, researchers should consider the following experimental design:

• Time course: Analyze multiple time points (0, 1, 10, 30, and 60 minutes) following stimulation

• Stimulation methods:

  • Co-culture with target cells (e.g., HPAC pancreatic cancer cells for PSCA-specific CAR-T cells)

  • Plate-bound anti-CD28 antibodies

  • Soluble anti-CD28 antibodies with cross-linking

• Cell types: Primary T cells, Jurkat cells, and CAR-T cells provide complementary insights

• Detection method: Western blotting with phospho-specific antibodies

• Controls: Include Y218F mutant cells as negative controls

Studies have demonstrated that Y218 phosphorylation is antigen-dependent and reaches maximum levels approximately 10 minutes post-stimulation, making this a critical time point to include .

What are the recommended antibody dilutions and experimental conditions for Western blotting?

For optimal Western blot results when detecting phospho-CD28 (Y218), the following conditions are recommended:

Additional considerations:

• Blocking: 5% BSA in TBST (not milk, which contains phosphatases)

• Secondary antibody: Anti-rabbit IgG HRP (1:5000 - 1:10000)

• Sample preparation: Include phosphatase inhibitors in lysis buffer

• Membrane washing: Minimum 3 x 10 minutes with TBST

These recommendations are based on commercial antibody specifications and published protocols .

How does CD28-Y218 phosphorylation affect IL-2 production and T cell function?

CD28-Y218 phosphorylation plays a crucial role in regulating IL-2 production in T cells. Mutation studies replacing Y218 with a non-phosphorylatable amino acid (Y218F) have demonstrated:

• Significantly reduced IL-2 and TNFα secretion in vitro following antigen stimulation

• Impaired T cell proliferation and survival in long-term culture

• Decreased antitumor efficacy in vivo in preclinical models

These effects appear to be specific to cytokine production, as the Y218F mutation does not substantially affect CAR expression or immediate cytotoxic function against target cells. This suggests that Y218 phosphorylation represents a specialized signaling node that selectively regulates cytokine production pathways without globally disrupting T cell activation .

What is the relationship between SNX9 and CD28-Y218 phosphorylation?

Sorting nexin 9 (SNX9) has been identified as a critical factor that specifically contributes to CD28-Y218 phosphorylation. Research using SNX9 knockout Jurkat T cells has demonstrated:

• SNX9 knockout cells show a significant decrease (40% ± 19.2%) in CD28 phosphorylation compared to wild-type cells

• This effect is specific to CD28, as TCR phosphorylation remained unchanged in SNX9 knockout cells

• SNX9 appears to regulate CD28 cluster stability through membrane tubulation

These findings suggest a model wherein SNX9-mediated tubulation generates a membrane environment that promotes CD28 triggering and subsequent phosphorylation of Y218, facilitating downstream signaling events. This mechanism represents a previously unrecognized level of regulation in CD28 signaling pathways .

How does CD28-Y218 phosphorylation integrate with other T cell signaling pathways?

CD28-Y218 phosphorylation integrates with multiple signaling pathways in T cells:

• ITK pathway: ITK mediates Y218 phosphorylation and is recruited to CD28, creating a potential feedback loop

• PI3K/AKT pathway: Y218 phosphorylation influences PI3K activity, though less directly than Y191 (YMNM motif)

• NF-κB activation: Y218 phosphorylation contributes to sustained NF-κB signaling

• Cytoskeletal reorganization: Through interaction with SNX9, Y218 phosphorylation affects membrane dynamics

This complex integration allows CD28-Y218 phosphorylation to selectively influence specific aspects of T cell function, particularly cytokine production, while working in concert with other CD28 signaling motifs and TCR-derived signals .

How does CD28-Y218 phosphorylation impact CAR-T cell design and function?

CD28-Y218 phosphorylation has significant implications for CAR-T cell design and function:

• Therapeutic efficacy: Y218F mutation completely abrogated the therapeutic effect of PSCA-specific CAR-T cells in a pancreatic cancer model, despite minimal effects on in vitro cytotoxicity

• Persistence: CAR-T cells with intact Y218 show improved in vivo persistence, likely due to enhanced IL-2 production

• Design optimization: Creating CARs with enhanced ITK binding sites near the CD28 C-terminus (PYRP mutant) increases IL-2 production approximately 2-fold

• Target-dependent activation: Y218 phosphorylation is antigen-dependent, providing a potential mechanism to modulate CAR-T activity

These findings suggest that CD28-Y218 phosphorylation represents a critical design parameter that should be considered when developing next-generation CAR-T therapies, particularly for solid tumors where sustained activity and cytokine production are essential .

What experimental models are most suitable for studying CD28-Y218 phosphorylation in CAR-T cells?

Several experimental models have proven valuable for studying CD28-Y218 phosphorylation in CAR-T cells:

• In vitro models:

  • PSCA-specific CAR-T cells cocultured with HPAC pancreatic cancer cells

  • CD19-specific CAR-T cells with NALM6 target cells expressing firefly luciferase

  • xCELLigence Real-Time Cytotoxicity Assay for functional readouts

  • ELLA system for cytokine quantification

• In vivo models:

  • NSG mice with subcutaneous HPAC tumors receiving intravenous CAR-T infusions

  • Bioluminescence imaging for tracking tumor burden

  • Flow cytometry analysis of circulating CAR-T cells

• Molecular tools:

  • Y218F mutant CARs as negative controls

  • PYRP mutant CARs for enhanced ITK binding

  • ITK inhibitors (BMS-509744, Ibrutinib) for mechanistic studies

These complementary approaches allow comprehensive characterization of CD28-Y218 phosphorylation in different contexts and its impact on CAR-T cell function .

How can analysis of CD28-Y218 phosphorylation resolve contradictory data in CAR-T cell studies?

Analyzing CD28-Y218 phosphorylation can help resolve several common contradictions in CAR-T cell research:

• In vitro versus in vivo efficacy: CAR-T cells with Y218F mutation show minimal reduction in cytotoxicity in vitro but completely lose therapeutic efficacy in vivo, suggesting Y218 phosphorylation primarily affects persistence and sustained function rather than immediate killing capacity

• Cytokine production versus tumor killing: Y218 phosphorylation specifically regulates IL-2 and TNFα production without substantially affecting immediate cytotoxic function, explaining why some CAR constructs may kill effectively in short-term assays but fail to persist long-term

• CD28 versus 4-1BB costimulation: Differences in Y218 phosphorylation dynamics may contribute to the distinct cytokine profiles and persistence characteristics of these costimulatory domains

• Cell type-specific effects: Variations in ITK expression and activity between different T cell subsets could explain differential responses to the same CAR construct

By examining Y218 phosphorylation in these contexts, researchers can gain mechanistic insights into apparently contradictory findings and design more effective CAR-T cell therapies .

What are common pitfalls when detecting CD28-Y218 phosphorylation and how can they be avoided?

Several technical challenges can complicate the detection of CD28-Y218 phosphorylation:

• Low signal intensity: Y218 phosphorylation is less abundant than Y191 and Y209 phosphorylation

  • Solution: Optimize cell stimulation conditions and timing (peak at ~10 minutes)

  • Solution: Use signal enhancement techniques such as TSA amplification

• High background in Western blots:

  • Solution: Use 5% BSA instead of milk for blocking and antibody dilution

  • Solution: Increase washing duration and frequency (minimum 3 x 10 minutes)

• Cell type heterogeneity:

  • Solution: Use flow cytometry with phospho-specific antibodies for single-cell resolution

  • Solution: Sort cells before analysis to ensure homogeneous populations

• Rapid dephosphorylation:

  • Solution: Include multiple phosphatase inhibitors in lysis buffer

  • Solution: Maintain samples at 4°C throughout processing

• Antibody cross-reactivity:

  • Solution: Include Y218F mutant cells as negative controls

  • Solution: Validate with multiple detection methods (Western blot and ELISA)

These approaches can significantly improve the reliability and sensitivity of CD28-Y218 phosphorylation detection .

How should researchers interpret variation in CD28-Y218 phosphorylation levels between experiments?

When interpreting variations in CD28-Y218 phosphorylation across experiments, researchers should consider:

• Technical factors:

  • Antibody lot-to-lot variation: Compare with internal controls and normalize accordingly

  • Cell stimulation conditions: Minor differences in temperature or timing can affect results

  • Cell culture conditions: Passage number and density influence receptor expression

• Biological factors:

  • T cell subset differences: Naïve, memory, and effector T cells show distinct phosphorylation kinetics

  • Donor variability: Genetic differences affect baseline and inducible phosphorylation

  • Activation state: Previously activated cells may show altered phosphorylation patterns

• Analysis considerations:

  • Normalization method: Total CD28 levels should be quantified alongside phosphorylation

  • Time course analysis: Single time points may miss the peak of phosphorylation

  • Quantification approach: Western blot densitometry has higher variability than flow cytometry

By systematically addressing these factors, researchers can determine whether variations represent technical inconsistencies or biologically meaningful differences .

What advanced analytical techniques can enhance investigation of CD28-Y218 phosphorylation dynamics?

Several advanced techniques can provide deeper insights into CD28-Y218 phosphorylation dynamics:

• Phosphoproteomic mass spectrometry:

  • SILAC-based quantitative phosphoproteomics to identify phosphorylation stoichiometry

  • Parallel reaction monitoring (PRM) for absolute quantification

  • Provides comprehensive view of phosphorylation networks

• Live-cell imaging:

  • FRET-based biosensors for real-time phosphorylation monitoring

  • Super-resolution microscopy to visualize CD28 clustering and phosphorylation

  • Correlative light and electron microscopy for membrane dynamics

• Computational approaches:

  • Kinetic modeling of phosphorylation/dephosphorylation cycles

  • Network analysis to identify signaling nodes influenced by Y218 phosphorylation

  • Machine learning to predict functional outcomes from phosphorylation patterns

• Single-cell analysis:

  • Mass cytometry (CyTOF) with phospho-specific antibodies

  • Single-cell RNA-seq to correlate phosphorylation with transcriptional outcomes

  • Spatial proteomics to map phosphorylation events in the immunological synapse

These technologies can reveal context-dependent regulation of CD28-Y218 phosphorylation and its functional consequences at unprecedented resolution .